Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2022

MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in … Continue reading

Posted in Golden Matrix Group Inc. GMGI | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Leveraging Strategic Developments to Bring Its FIVE EV Crossover to Market

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently reported the results of its solid-state polymer battery testing. According to a recent article that contains excerpts from a Benzinga Brief, “Testing results from BIC [Battery Innovation Center] show … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Aggressively Developing, Expanding Supply Capabilities to Cater to Growing Demand

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) develops, owns and operates projects that take organic waste and convert that into renewable energy in the form of renewable natural gas (“RNG). “[Canadian utilities, like FortisBC] offer 20-year contracted offtakes to companies like ours … Continue reading

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

iGaming Legalized in Ontario, Golden Matrix Group Inc. (NASDAQ: GMGI) Positioned to Benefit from Relaxed Legislation

Canadian province of Ontario recently legalized iGaming, other provinces expected to followiGaming industry expected to reach 153.6 billion by 2030 at CAGR of 11.7% from 2022 to 2030GMGI offers highly modular, turnkey, and white label gaming solutions for growing B2B … Continue reading

Posted in Golden Matrix Group Inc. GMGI | Leave a comment

From West to East, EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Stretching its RNG Footprint Across Canada

Formed just two years ago, EverGen began with the acquisition of two waste-to-energy facilities in British ColumbiaIn the last two months, EverGen has expanded its Canadian presence, making acquisitions of facilities and projects in Alberta and OntarioThe company is targeting … Continue reading

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

DPCM Capital Inc. (NYSE: XPOA) and D-Wave Systems Inc. Highlight Unique Bonus Pool Structure for Up to 5 Million Shares to be Allocated Pro-Rata to Non-Redeeming DPCM Capital Stockholders

DPCM Capital stockholders have been offered an innovative bonus pool structure that incentivizes stockholders and reduces their cost basis per share by as much as 31%The bonus pool is highlighted ahead of the July 29, 2022 redemption deadline to incentivize … Continue reading

Posted in DPCM Capital Inc. XPOA | Leave a comment

MissionIRNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted … Continue reading

Posted in QSAM Biosciences Inc. QSAM | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting at the 42nd annual Canaccord Genuity Growth Conference; the four-day event is scheduled for Aug. 8–11, 2022, in Boston. During the conference, Cybin … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Cleared for Historic Study, Begins Enrolling Participants

Company receives FDA “may proceed” letter and investigational new drug (“IND”) application clearanceEnrollment for Phase 1/2a trial has already startedUpcoming trial is first time a psilocybin analog will be evaluated for MDD treatmentStudies show psychedelic-based treatments may have potential to … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and … Continue reading

Posted in Flora Growth Corp. FLGC | Leave a comment